Fetal warfarin syndrome

Fetal warfarin syndrome (FWS) is a rare condition that occurs in a developing fetus when the mother takes the anticoagulant medication warfarin during pregnancy. This syndrome is characterized by a range of congenital abnormalities, primarily affecting the skeletal system, central nervous system, and facial features.
Causes
Fetal warfarin syndrome is caused by the teratogenic effects of warfarin, a vitamin K antagonist, which interferes with the normal development of the fetus. Warfarin crosses the placenta and can disrupt the synthesis of vitamin K-dependent clotting factors, leading to hemorrhages and subsequent developmental anomalies.
Symptoms
The symptoms of fetal warfarin syndrome can vary but often include:
- Nasal hypoplasia (underdeveloped nasal bridge)
- Stippled epiphyses (small, round calcifications in the cartilage of the long bones)
- Limb hypoplasia (underdeveloped limbs)
- Central nervous system abnormalities, such as microcephaly and intellectual disabilities
- Eye abnormalities, including optic atrophy and cataracts
- Congenital heart defects
Diagnosis
Diagnosis of fetal warfarin syndrome is typically based on a combination of maternal history of warfarin use during pregnancy and the presence of characteristic physical findings in the newborn. Prenatal ultrasound may detect some of the skeletal abnormalities, but a definitive diagnosis is often made postnatally.
Treatment
There is no specific treatment for fetal warfarin syndrome. Management focuses on addressing the individual symptoms and may include:
- Surgical correction of skeletal deformities
- Special education and developmental support for intellectual disabilities
- Regular monitoring and treatment of heart defects
Prevention
The primary method of preventing fetal warfarin syndrome is to avoid the use of warfarin during pregnancy. Alternative anticoagulants, such as heparin, which do not cross the placenta, are often recommended for pregnant women who require anticoagulation therapy.
Related Pages
References
External Links
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
